SEC Filing Details
PTC Therapeutics, Inc. is committed to serving the interests of all our stakeholders.
Living with
Duchenne Muscular Dystrophy,
Ukraine
SEC Filing Details
Document Details
Form
Filing Date
Jul 17, 2023
Document Date
Jul 13, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
PTC Therapeutics, Inc.
Issuer
PTC THERAPEUTICS, INC.
Filer
GRAVIER PIERRE